These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 16380770

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, Mills AS.
    Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
    [Abstract] [Full Text] [Related]

  • 3. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Carpino G, Morini S, Ginanni Corradini S, Franchitto A, Merli M, Siciliano M, Gentili F, Onetti Muda A, Berloco P, Rossi M, Attili AF, Gaudio E.
    Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
    Carpino G, Franchitto A, Morini S, Corradini SG, Merli M, Gaudio E.
    Ital J Anat Embryol; 2004 May; 109(4):225-38. PubMed ID: 15717457
    [Abstract] [Full Text] [Related]

  • 6. Prognostic analysis in chronic hepatitis B patients: a retrospective study of 216 cases about Scheuer scores, in situ expression of viral antigens and tissue hepatitis B virus DNA levels.
    Zhu R, Huang H, Zhang H, Wang Z, Hu X, Zhai W, Lin Y, Wang J, Zhu H.
    Liver Int; 2006 Feb; 26(1):82-9. PubMed ID: 16420513
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver.
    Washington K, Wright K, Shyr Y, Hunter EB, Olson S, Raiford DS.
    Hum Pathol; 2000 Jul; 31(7):822-8. PubMed ID: 10923919
    [Abstract] [Full Text] [Related]

  • 12. Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy.
    Khan MA, Poulos JE, Brunt EM, Li L, Solomon H, Britton RS, Bacon BR, Di Bisceglie AM.
    Hepatogastroenterology; 2001 Jul; 48(37):212-5. PubMed ID: 11268968
    [Abstract] [Full Text] [Related]

  • 13. The value of alpha-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathological and immunohistochemical study.
    Akpolat N, Yahsi S, Godekmerdan A, Yalniz M, Demirbag K.
    Histopathology; 2005 Sep; 47(3):276-80. PubMed ID: 16115228
    [Abstract] [Full Text] [Related]

  • 14. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.
    Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R, Pigeyre M, Verkindt H, Dharancy S, Louvet A, Romon M, Pattou F.
    Gastroenterology; 2009 Aug; 137(2):532-40. PubMed ID: 19409898
    [Abstract] [Full Text] [Related]

  • 15. In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers.
    Hellerbrand C, Bataille F, Schlegel J, Hartmann A, Mühlbauer M, Schölmerich J, Büttner R, Hofstädter F, Bosserhoff AK.
    Liver Int; 2005 Apr; 25(2):357-66. PubMed ID: 15780062
    [Abstract] [Full Text] [Related]

  • 16. Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis.
    Cortez-Pinto H, Baptista A, Camilo ME, de Moura MC.
    Hepatogastroenterology; 2001 Apr; 48(37):87-90. PubMed ID: 11269008
    [Abstract] [Full Text] [Related]

  • 17. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, George J.
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [Abstract] [Full Text] [Related]

  • 18. Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD.
    Boursier J, Chaigneau J, Roullier V, Lainé F, Sandrini J, Michalak S, Hubert I, Dib N, Oberti F, Bertrais S, Hunault G, Deugnier Y, Rousselet MC, Cavaro-Ménard C, Gallois Y, Aubé C, Calès P, Study group UNAM-METABOL.
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):974-81. PubMed ID: 21904208
    [Abstract] [Full Text] [Related]

  • 19. Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease?
    Canbakan B, Senturk H, Canbakan M, Toptas T, Tabak O, Balci H, Olgac V, Ozbay G.
    Biomark Med; 2010 Apr; 4(2):205-14. PubMed ID: 20406065
    [Abstract] [Full Text] [Related]

  • 20. Disease- and cell-specific expression of GP73 in human liver disease.
    Iftikhar R, Kladney RD, Havlioglu N, Schmitt-Gräff A, Gusmirovic I, Solomon H, Luxon BA, Bacon BR, Fimmel CJ.
    Am J Gastroenterol; 2004 Jun; 99(6):1087-95. PubMed ID: 15180730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.